IndraLab
Statements
Amodiaquine inhibits CTSB. 4 / 5
1
|
4
reach
"Approved drugs already have well-established
safety and pharmacokinetic (PK) profiles in humans and animals as
well as existing manufacturing and distribution networks, which would
potentially accelerate their approval.It has been previously
discovered that a small molecule antimalarial
amodiaquine (AQ) effectively inhibited LF-PA cytotoxicity by targeting
host Ctsb."